Understanding the Future of Hemophilia B Care
Hosted by Dr. David Clark, Live-Streamed in the B-Hub
October 7: Understanding a Rebalancing Therapy Option for Hemophilia
Understanding a Rebalancing Therapy Option for Hemophilia
Sponsored by Pfizer
Speaker: Brad Schoenfeld, Director of Advocacy and Community Engagement, Pfizer
Hosted by: Dr. David Clark
Understanding a Rebalancing Therapy Option for Hemophilia
Description -
Join us for an educational session exploring a rebalancing treatment option for hemophilia.
You’ll hear:
• The science behind rebalancing therapy
• Clinical trial data
• Safety information
• Information on administration
• Shared decision-making tips for patients and caregivers
In this session, we’ll dive into a rebalancing treatment option. From how it works to clinical trial learnings, you’ll gain the latest information to help you or your loved ones understand this treatment option with confidence.
